<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03461510</url>
  </required_header>
  <id_info>
    <org_study_id>17-35</org_study_id>
    <nct_id>NCT03461510</nct_id>
  </id_info>
  <brief_title>Type 2 Diabetes and the Brain in Adolescents</brief_title>
  <official_title>Dysglycemia &amp; Obesity: Impact on the Brain in Adolescents With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nemours Children's Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nemours Children's Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates differences in brain function and cognitive performance in adolescents
      with type 2 diabetes (T2D) compared to non diabetic controls (both obese and lean) and
      correlates these changes with obesity, insulin resistance, and glycemic control in youth with
      T2D.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a cross-sectional study examining neurocognitive function and brain activity in
      resting state and during working memory and executive function tasks using blood oxygen level
      dependent (BOLD) functional MRI (fMRI) during hyperinsulinemic euglycemic and hyperglycemic
      clamps in obese adolescents with T2D compared to non-diabetic obese and lean controls. The
      investigators will measure glycemic control (acute hyperglycemia during clamps and glycemic
      variability) and insulin resistance to examine their association with neurocognitive metrics
      and brain functional activity.

      There will be one screening visit and three study visits for subjects with T2D. One visit
      will consist of neurocognitive testing and dual energy X-ray absorptiometry (DEXA) of the
      whole body to assess body composition including fat mass. In the other two visits, subjects
      with T2D will undergo normal and high glucose clamps during fMRI.

      Obese and lean control subjects will have one screening visit and two study visits, one for
      neurocognitive testing and DEXA and another for fMRI without glucose clamps. All subjects
      will have a blood sample obtained at the screening visit.

      Only adolescents with type 2 diabetes will wear a continuous glucose monitor (CGM) for 6 days
      prior to neuroimaging to determine glycemic variability. A1C will be assessed at baseline.

      Parents of subjects will also have abbreviated IQ testing.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 8, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain Activity using functional MRI (fMRI)</measure>
    <time_frame>Baseline</time_frame>
    <description>The investigators will examine functional connectivity of brain networks during cross sectional resting-state and task-related (working memory and response inhibition) BOLD-fMRI activation. fMRI activation in adolescents with T2D will be compared to age- and sex- matched, non-diabetic, healthy lean and obese controls.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurocognitive battery metrics including IQ as well as executive function and visual-spatial memory</measure>
    <time_frame>Baseline</time_frame>
    <description>The investigators will evaluate cognitive performance by examining test scores from neurocognitive metrics which reflect global IQ, spatial recognition, episodic memory, executive function (includes response inhibition, working memory), academic achievement, and processing speed. Adolescents with T2D will be compared to controls to determine whether these differences are associated with glycemic control, obesity, and insulin resistance.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fMRI performance in relation to dysglycemia</measure>
    <time_frame>Baseline</time_frame>
    <description>In adolescents with T2D, the investigators will examine BOLD-fMRI brain activation in relation to acute hyperglycemia during glucose clamping, chronic hyperglycemia, glycemic variability, and insulin resistance.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Obesity</condition>
  <condition>Pediatric Obesity</condition>
  <condition>Insulin Resistance</condition>
  <condition>Dysglycemia</condition>
  <arm_group>
    <arm_group_label>Type 2 Diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hyperglycemic clamp and Hyperinsulinemic Euglycemic clamp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lean Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Controls do not undergo Hyperglycemic clamp and Hyperinsulinemic Euglycemic clamp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Controls do not undergo Hyperglycemic clamp and Hyperinsulinemic Euglycemic clamp</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hyperglycemic clamp</intervention_name>
    <description>Subjects with T2D will receive IV Dextrose infusion to maintain plasma glucose at ~250 mg/dL during fMRI.</description>
    <arm_group_label>Type 2 Diabetes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hyperinsulinemic Euglycemic clamp</intervention_name>
    <description>Subjects with T2D will receive IV Dextrose and Insulin infusion to maintain plasma glucose at approximately 90 mg/dL during fMRI.</description>
    <arm_group_label>Type 2 Diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Type 2 Diabetes:

          -  BMI ≥85th percentile

          -  A1c ≥ 8%

          -  Pubertal

        Healthy Controls:

          -  BMI ≥85th percentile for Obese Controls

          -  BMI &lt; 85th percentile for Lean Controls

          -  Pubertal

          -  Normal A1c &amp; Fasting glucose

        Exclusion Criteria:

          -  Significant developmental delay or learning disability

          -  Significant visual or auditory deficits

          -  Born &lt;34 weeks gestation

          -  Neurologic disease

          -  Psychiatric disease requiring inpatient treatment

          -  Significant head trauma

          -  Malignancy

          -  Pregnancy

          -  Weight &gt; 350lb (MRI weight limit)

          -  Metal in the body (including dental braces)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lydia Snyder, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nemours Children's Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kaitlin M Sikes, ARNP</last_name>
    <phone>904-697-3988</phone>
    <email>ksikes@nemours.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nemours Children's Health System</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaitlin M Sikes, ARNP</last_name>
      <phone>904-697-3988</phone>
      <email>ksikes@nemours.org</email>
    </contact>
    <investigator>
      <last_name>Lydia Snyder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mazaika PK, Weinzimer SA, Mauras N, Buckingham B, White NH, Tsalikian E, Hershey T, Cato A, Aye T, Fox L, Wilson DM, Tansey MJ, Tamborlane W, Peng D, Raman M, Marzelli M, Reiss AL; Diabetes Research in Children Network (DirecNet). Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes. Diabetes. 2016 Feb;65(2):476-85. doi: 10.2337/db15-1242. Epub 2015 Oct 28.</citation>
    <PMID>26512024</PMID>
  </reference>
  <reference>
    <citation>Mauras N, Mazaika P, Buckingham B, Weinzimer S, White NH, Tsalikian E, Hershey T, Cato A, Cheng P, Kollman C, Beck RW, Ruedy K, Aye T, Fox L, Arbelaez AM, Wilson D, Tansey M, Tamborlane W, Peng D, Marzelli M, Winer KK, Reiss AL; Diabetes Research in Children Network (DirecNet). Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes. 2015 May;64(5):1770-9. doi: 10.2337/db14-1445. Epub 2014 Dec 8.</citation>
    <PMID>25488901</PMID>
  </reference>
  <reference>
    <citation>Marzelli MJ, Mazaika PK, Barnea-Goraly N, Hershey T, Tsalikian E, Tamborlane W, Mauras N, White NH, Buckingham B, Beck RW, Ruedy KJ, Kollman C, Cheng P, Reiss AL; Diabetes Research in Children Network (DirecNet). Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes. 2014 Jan;63(1):343-53. doi: 10.2337/db13-0179. Epub 2013 Oct 29.</citation>
    <PMID>24170697</PMID>
  </reference>
  <reference>
    <citation>Bruehl H, Sweat V, Tirsi A, Shah B, Convit A. Obese Adolescents with Type 2 Diabetes Mellitus Have Hippocampal and Frontal Lobe Volume Reductions. Neurosci Med. 2011 Mar 1;2(1):34-42.</citation>
    <PMID>21691448</PMID>
  </reference>
  <reference>
    <citation>Yau PL, Javier DC, Ryan CM, Tsui WH, Ardekani BA, Ten S, Convit A. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia. 2010 Nov;53(11):2298-306. doi: 10.1007/s00125-010-1857-y. Epub 2010 Jul 30.</citation>
    <PMID>20668831</PMID>
  </reference>
  <reference>
    <citation>Yau PL, Kang EH, Javier DC, Convit A. Preliminary evidence of cognitive and brain abnormalities in uncomplicated adolescent obesity. Obesity (Silver Spring). 2014 Aug;22(8):1865-71. doi: 10.1002/oby.20801. Epub 2014 May 28.</citation>
    <PMID>24891029</PMID>
  </reference>
  <reference>
    <citation>Cui Y, Jiao Y, Chen YC, Wang K, Gao B, Wen S, Ju S, Teng GJ. Altered spontaneous brain activity in type 2 diabetes: a resting-state functional MRI study. Diabetes. 2014 Feb;63(2):749-60. doi: 10.2337/db13-0519. Epub 2013 Dec 18.</citation>
    <PMID>24353185</PMID>
  </reference>
  <reference>
    <citation>Marder TJ, Flores VL, Bolo NR, Hoogenboom WS, Simonson DC, Jacobson AM, Foote SE, Shenton ME, Sperling RA, Musen G. Task-induced brain activity patterns in type 2 diabetes: a potential biomarker for cognitive decline. Diabetes. 2014 Sep;63(9):3112-9. doi: 10.2337/db13-1783. Epub 2014 Apr 4.</citation>
    <PMID>24705405</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2018</study_first_submitted>
  <study_first_submitted_qc>March 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2018</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nemours Children's Clinic</investigator_affiliation>
    <investigator_full_name>Lydia Snyder</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Cognition</keyword>
  <keyword>MRI</keyword>
  <keyword>Functional MRI</keyword>
  <keyword>Pediatric Obesity</keyword>
  <keyword>Type 2 Diabetes Mellitus</keyword>
  <keyword>Adolescents</keyword>
  <keyword>Continuous Glucose Monitoring</keyword>
  <keyword>Insulin Clamp</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Pediatric Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

